Performance of TXG 10X Genomics | -67.9% in 12m
Compare TXG with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare 10X Genomics with its related Sector/Index XLV
Performance Duell TXG vs XLV
| TimeFrame | TXG | XLV |
|---|---|---|
| 1 Day | 1.51% | 0.56% |
| 1 Week | 21.1% | 1.41% |
| 1 Month | 3.69% | 2.64% |
| 3 Months | -26.7% | 7.56% |
| 6 Months | -53.2% | 8.49% |
| 12 Months | -67.9% | 13.60% |
| YTD | -62.8% | 8.87% |
| Rel. Perf. 1m | -0.14 | |
| Rel. Perf. 3m | -7.13 | |
| Rel. Perf. 6m | -8.45 | |
| Rel. Perf. 12m | -8.45 |
Is 10X Genomics a good stock to buy?
No, based on ValueRay Fundamental Analyses, 10X Genomics (NASDAQ:TXG) is currently (July 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -54.30 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of July 2024 is 15.45. This means that TXG is currently overvalued and has a potential downside of -23.59% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of July 2024 is 15.45. This means that TXG is currently overvalued and has a potential downside of -23.59% (Sold with Premium).
Is TXG a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 8
- Sell: 1
- Strong Sell: 0
Values above 0%: TXG is performing better - Values below 0%: TXG is underperforming
Compare TXG with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 21.91% | 3.89% | -65.63% | -88.48% |
| US NASDAQ 100 | QQQ | 23.66% | 7.31% | -62.78% | -89.39% |
| US Dow Jones Industrial 30 | DIA | 20.33% | -0.12% | -60.68% | -84.16% |
| German DAX 40 | DBXD | 19.69% | 2.25% | -61.32% | -82.75% |
| UK FTSE 100 | ISFU | 19.89% | 1.08% | -64.77% | -83.06% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 24.08% | 3.99% | -55.34% | -52.30% |
| Hongkong Hang Seng | HSI | 22.50% | 4.47% | -49.22% | -47.88% |
| Japan Nikkei 225 | EXX7 | 22.59% | 4.84% | -54.76% | -78.80% |
| India NIFTY 50 | INDA | 19.94% | 0.79% | -68.73% | -94.83% |
| Brasil Bovespa | EWZ | 22.01% | 2.30% | -39.09% | -55.49% |
TXG 10X Genomics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.74% | 6.32% | -61.55% | -90.82% |
| Consumer Discretionary | XLY | 23.85% | 4.08% | -60.05% | -73.83% |
| Consumer Staples | XLP | 20.57% | 2.08% | -62.91% | -74.57% |
| Energy | XLE | 21.27% | 1.92% | -64.41% | -76.80% |
| Financial | XLF | 19.77% | -2.14% | -66.40% | -92.88% |
| Health Care | XLV | 19.67% | 1.05% | -61.71% | -81.49% |
| Industrial | XLI | 19.93% | -0.10% | -65.29% | -84.12% |
| Materials | XLB | 19.73% | 0.60% | -64.84% | -76.60% |
| Real Estate | XLRE | 20.54% | -4.18% | -60.84% | -78.38% |
| Technology | XLK | 23.16% | 8.09% | -60.79% | -90.10% |
| Utilities | XLU | 19.60% | 0.23% | -71.40% | -77.64% |
| Aerospace & Defense | XAR | 17.44% | -2.00% | -68.30% | -87.62% |
| Biotech | XBI | 16.95% | -6.45% | -68.44% | -88.52% |
| Homebuilder | XHB | 16.79% | -12.31% | -77.03% | -107.23% |
| Retail | XRT | 18.99% | 1.06% | -64.33% | -83.38% |
Does 10X Genomics outperform its market, is TXG a Sector Leader?
No, over the last 12 months 10X Genomics (TXG) made -67.89%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.60%.
Over the last 3 months TXG made -26.71%, while XLV made 7.56%.
No, over the last 12 months 10X Genomics (TXG) made -67.89%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.60%.
Over the last 3 months TXG made -26.71%, while XLV made 7.56%.
| Period | TXG | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.69% | 2.64% | -0.20% |
| 3 Months | -26.71% | 7.56% | 7.46% |
| 12 Months | -67.89% | 13.60% | 20.59% |